Biogen, LendingClub, IBM, and More: Here’s What Analysts Had to Say About These Five Stocks

LendingClub Corp (NYSE:LC) is 2% in the green after Eric Wasserstrom of Guggenheim upgraded the stock to ‘Buy’ from ‘Neutral’, setting a $7 price target. Shares of the company are now in the green year-to-date and trade for around 26 times forward earnings estimates. The number of elite funds with holdings in LendingClub Corp (NYSE:LC) fell by 3 quarter-over-quarter to 21 at the end of December.

Shares of Warren Buffett’s other favorite tech company (outside of Apple) International Business Machines Corp. (NYSE:IBM) are up almost 1% after Katy Huberty of Morgan Stanley hiked her price target to $212 per share from $187 and maintained her ‘Overweight’ stance on the name. Huberty likes IBM’s fast growing and relatively high margin cloud opportunity. Of the 742 elite funds we track, 52 funds owned $15.23 billion of International Business Machines Corp. (NYSE:IBM) and accounted for 9.60% of the float on December 31, versus 55 funds and $14.65 billion respectively on September 30.

Last but not least, Roth Capital analyst Brian Alger hiked his price target on Intevac, Inc. (NASDAQ:IVAC) to $14.30 from $11.25 per share due to improved visibility from the order of twelve Energi systems that were recently announced. Due to that increased visibility, Alger thinks Intevac’s multiple should trade more in line with its peers. 7 top funds had a bullish position in Intevac, Inc. (NASDAQ:IVAC) at the end of December, unchanged from that of the previous quarter.

Disclosure:None